Abstract
Aims
Recent advances in therapy led to a significant decrease in mortality and morbidity after myocardial infarction (MI). However, little is known about quality of life (QoL) after MI. We examined heart failure (HF)-related quality-of-life (QoL) impairment, its trajectories, and determinants after MI.
Methods
Data from a single-center prospectively designed registry of consecutive patients hospitalized for MI at a large tertiary cardiology center were utilized. At 1 month and 1 year after hospital discharge, patients completed the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Results
In total, 850 patients (aged 65 ± 12 years, 27% female) hospitalized between June 2017 and October 2020 completed KCCQ at 1 month after discharge. Of these, 38.7% showed HF-related QoL impairment (KCCQ ≤ 75). In addition to characteristics of MI (MI size, diuretics need, heart rate), comorbidities as renal dysfunction and anemia were associated with QoL impairment. Of the 673 eligible, 500 patients (74.3%) completed KCCQ at 1 year after MI. On average, QoL improved by 5.9 ± 16.8 points during the first year after MI (p < 0.001); but, in 18% of patients QoL worsened. Diabetes control and hemoglobin level at the time of hospitalization were associated with QoL worsening.
Conclusion
Two out of 5 patients after MI present with HF-related QoL impairment. In addition to guideline-directed MI management, careful attention to key non-cardiac comorbidities as chronic kidney disease, anemia and diabetes may lead to further augmentation of the benefit of modern therapies in terms of QoL.
Graphical abstract
Similar content being viewed by others
Abbreviations
- CAD:
-
Coronary artery disease
- HF:
-
Heart failure
- KCCQ:
-
Kansas City Cardiomyopathy Questionnaire
- MI:
-
Myocardial infarction
- PCI:
-
Percutaneous coronary intervention
- PRO:
-
Patient-reported outcomes
- QoL:
-
Quality of life
References
Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C et al (2017) Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014. Eur Heart J 38:3056–3065
Thompson DR, Yu C-M (2003) Quality of life in patients with coronary heart disease-I: assessment tools. Health Qual Life Outcomes 1:42
Wolfe A (2001) Institute of medicine report: crossing the quality chasm: a new health care system for the 21st century. Policy Polit Nurs Pract 2:233–235
Rumsfeld JS, Alexander KP, Goff DC, Graham MM, Ho PM, Masoudi FA et al (2013) Cardiovascular health: the importance of measuring patient-reported health status. Circulation 127:2233–2249
Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS et al (2006) Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol 47:752–756
Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV et al (2017) Association of serial Kansas City cardiomyopathy questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials. JAMA cardiology 2:1315–1321
Mishra RK, Yang W, Roy J, Anderson AH, Bansal N, Chen J et al (2015) Kansas city cardiomyopathy questionnaire score is associated with incident heart failure hospitalization in patients with chronic kidney disease without previously diagnosed heart failure. Circulation 8:702–708
Rumsfeld JS, Alexander KP, Goff DC, Graham MM, Ho PM, Masoudi FA et al (2013) Cardiovascular health: the importance of measuring patient-reported health status. Am Heart Assoc 127:2233–2249
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S et al (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63:1179–1194
Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13:227–236
Bahall M, Khan K (2018) Quality of life of patients with first-time AMI: a descriptive study. Health Qual Life Outcomes 16:32
Pilote L, Lauzon C, Huynh T, Dion D, Roux R, Racine N et al (2002) Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography. Arch Intern Med 162:553–559
Munyombwe T, Hall M, Dondo TB, Alabas OA, Gerard O, West RM et al (2020) Quality of life trajectories in survivors of acute myocardial infarction: a national longitudinal study. Heart (Br Cardiac Soc) 106:33–39
Mollon L, Bhattacharjee S (2017) Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis. Health Qual Life Outcomes 15:235
Staniūtė M, Brožaitienė J (2010) Changes in health-related quality of life among patients with coronary artery disease: a 2-year follow-up. Medicina (Kaunas) 46:843–850
Navarro MA, Gosch KL, Spertus JA, Rumsfeld JS, Ho PM (2016) Chronic kidney disease and health status outcomes following acute myocardial infarction. J Am Heart Assoc 5:e002772
Jenča D, Melenovský V, Stehlik J, Staněk V, Kettner J, Kautzner J et al (2021) Heart failure after myocardial infarction: incidence and predictors. ESC Heart Failure 8:222–237
Gerber Y, Weston SA, Enriquez-Sarano M, Berardi C, Chamberlain AM, Manemann SM et al (2016) Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ Heart Fail 9:e002460
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035
Kelkar AA, Spertus J, Pang P, Pierson RF, Cody RJ, Pina IL et al (2016) Utility of patient-reported outcome instruments in heart failure. JACC Heart Fail 4:165–175
Garin O, Herdman M, Vilagut G, Ferrer M, Ribera A, Rajmil L et al (2014) Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures. Heart Fail Rev 19:359–367
Green CP, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35:1245–1255
Spertus J, Peterson E, Conard MW, Heidenreich PA, Krumholz HM, Jones P et al (2005) Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 150:707–715
Butler J, Khan MS, Mori C, Filippatos GS, Ponikowski P, Comin-Colet J et al (2020) Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction. Eur J Heart Fail 22:999–1005
Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285–1295
Thomas DR (2010) Anemia and quality of life: association with diagnosis and treatment of anemias. In: Preedy VR, Watson RR (eds) Handbook of disease burdens and quality of life measures. Springer, New York, pp 1881–1893
Hayes A, Arima H, Woodward M, Chalmers J, Poulter N, Hamet P et al (2016) Changes in quality of life associated with complications of diabetes: results from the ADVANCE study. Value in Health 19:36–41
Goldney RD, Phillips PJ, Fisher LJ, Wilson DH (2004) Diabetes, depression, and quality of life. A population study. Diabetes Care 27:1066–1070
van der Wal HH, Grote Beverborg N, Dickstein K, Anker SD, Lang CC, Ng LL et al (2019) Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J 40:3616–3625
Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL et al (2020) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa575
Zhang J, Hu S, Jiang Y, Zhou Y (2020) Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials. Postgrad Med J 96:766–776
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V et al (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J 36:657–668
Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448
Zeller T, Waldeyer C, Ojeda F, Schnabel RB, Schäfer S, Altay A et al (2018) Adverse outcome prediction of iron deficiency in patients with acute coronary syndrome. Biomolecules 8:60
Kosiborod MN, Jhund PS, Docherty KF, Diez M, Petrie MC, Verma S et al (2020) Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction. Circulation 141:90–99
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413–1424
Funding
Supported by Ministry of Health of the Czech Republic, grant nr. NV 19–09-00125.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Wohlfahrt has received consulting fees or honoraria from Servier. Dr. Kautzner reports grants and personal fees from Biosense Webster, Biotronik, Boston Scientific, Medtronic, grants and personal fees from Abbott (SJM), personal fees from Merit Medical, Daiichi Sankyo, Boehringer Ingelheim, BMS, Bayer, Merck, MSD, Pfizer, all outside the submitted work. The other authors have nothing to disclose.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wohlfahrt, P., Jenča, D., Stehlik, J. et al. Heart failure-related quality-of-life impairment after myocardial infarction. Clin Res Cardiol 112, 39–48 (2023). https://doi.org/10.1007/s00392-022-02008-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-022-02008-z